Abbott Diabetes Care Inc & ors (appellants) v Dexcom Incorporated & ors (respondents)
Wednesday 5 November 2025
By Appellant’s Notice filed on 10 February 2025, the Appellant (Claimant below) Abbott Diabetes Care Inc and subsidiaries, appeal the decision of Mr Justice Mellor, sitting as a Judge of the High Court in the Intellectual Property List, judgment being delivered on 15 January 2025 following trial.
This is a patent case relating to continuous glucose monitoring technology, which now plays an important role in the management of type 1 diabetes. Abbott and Dexcom are the main players in this valuable market and are engaged in an ongoing patent dispute in which numerous patents are asserted by each side against the other in several jurisdictions.
View hearing: